CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $74,000 | +5.7% | 10,100 | 0.0% | 0.00% | – |
| Q4 2020 | $70,000 | +6.1% | 10,100 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | -74.3% | 10,100 | -58.3% | 0.00% | -100.0% |
| Q2 2019 | $257,000 | -23.1% | 24,200 | +64.6% | 0.00% | -50.0% |
| Q1 2019 | $334,000 | +87.6% | 14,700 | +21.5% | 0.00% | +100.0% |
| Q4 2018 | $178,000 | -46.7% | 12,100 | -17.7% | 0.00% | -50.0% |
| Q3 2018 | $334,000 | -3.2% | 14,700 | -2.6% | 0.00% | 0.0% |
| Q2 2018 | $345,000 | -54.7% | 15,100 | -44.3% | 0.00% | -60.0% |
| Q1 2018 | $761,000 | – | 27,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |